These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1506607)

  • 21. Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding.
    Oakes ND; Cooney GJ; Camilleri S; Chisholm DJ; Kraegen EW
    Diabetes; 1997 Nov; 46(11):1768-74. PubMed ID: 9356024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of hydrazine sulfate on abnormal carbohydrate metabolism in cancer patients with weight loss.
    Chlebowski RT; Heber D; Richardson B; Block JB
    Cancer Res; 1984 Feb; 44(2):857-61. PubMed ID: 6692384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbohydrate metabolism in renal failure.
    Fröhlich J; Schollmeyer P; Gerok W
    Am J Clin Nutr; 1978 Sep; 31(9):1541-6. PubMed ID: 28664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production.
    Toft I; Jenssen T
    Scand J Clin Lab Invest; 2005; 65(4):307-20. PubMed ID: 16076686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic substrate utilization by tumour and host tissues in cancer cachexia.
    Mulligan HD; Tisdale MJ
    Biochem J; 1991 Jul; 277 ( Pt 2)(Pt 2):321-6. PubMed ID: 1859359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hepatic and peripheral insulin resistance as a cause of hyperglycemia in non-insulin-dependent (type 2) diabetes mellitus: a review].
    Bratusch-Marrain P; Waldhäusl W
    Wien Klin Wochenschr; 1987 Apr; 99(7):211-6. PubMed ID: 3296467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between peripheral glucose utilisation and insulin sensitivity in the regulation of hepatic glucose production: studies in normal and alloxan-diabetic dogs.
    Christopher MJ; Rantzau C; Alford FP
    Diabetes Metab Res Rev; 2006; 22(2):155-67. PubMed ID: 16222656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic alterations in cancer. Part I. Carbohydrate metabolism.
    Levin L; Gevers W
    S Afr Med J; 1981 Apr; 59(15):518-21. PubMed ID: 7013105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic alterations in a noncachectic animal tumor system.
    Burt ME; Lowry SF; Gorschboth C; Brennan MF
    Cancer; 1981 May; 47(9):2138-46. PubMed ID: 7226107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathophysiology of cancer cachexia: current understanding and areas for future research.
    DeWys WD
    Cancer Res; 1982; 42(2 Suppl):721s-726s. PubMed ID: 7055813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of insulin in development of cancer cachexia in nongrowing sarcoma-bearing mice: special reference to muscle wasting.
    Svaninger G; Drott C; Lundholm K
    J Natl Cancer Inst; 1987 May; 78(5):943-50. PubMed ID: 3553691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mild type II diabetes markedly increases glucose cycling in the postabsorptive state and during glucose infusion irrespective of obesity.
    Efendic S; Karlander S; Vranic M
    J Clin Invest; 1988 Jun; 81(6):1953-61. PubMed ID: 3290257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin resistance and body composition in cancer patients.
    Dev R; Bruera E; Dalal S
    Ann Oncol; 2018 Feb; 29 Suppl 2():ii18-ii26. PubMed ID: 32169204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin secretion and action in noninsulin-dependent diabetes mellitus. Is insulin resistance secondary to hypoinsulinemia?
    Reaven GM; Chen YI; Coulston AM; Greenfield MS; Hollenbeck C; Lardinois C; Liu G; Schwartz H
    Am J Med; 1983 Nov; 75(5B):85-93. PubMed ID: 6369971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic Changes During Cancer Cachexia Pathogenesis.
    Shyh-Chang N
    Adv Exp Med Biol; 2017; 1026():233-249. PubMed ID: 29282687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus.
    Kolterman OG; Gray RS; Griffin J; Burstein P; Insel J; Scarlett JA; Olefsky JM
    J Clin Invest; 1981 Oct; 68(4):957-69. PubMed ID: 7287908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of metformin on insulin resistance and metabolic disorders in tumor-bearing rats with advanced cachexia.
    de Fatima Silva F; Ortiz-Silva M; Galia WBS; Cassolla P; da Silva FG; Graciano MFR; Carpinelli AR; de Souza HM
    Can J Physiol Pharmacol; 2018 May; 96(5):498-505. PubMed ID: 29304290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbohydrate metabolism and gestational diabetes.
    Catalano PM
    Clin Obstet Gynecol; 1994 Mar; 37(1):25-38. PubMed ID: 8194212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice.
    Asp ML; Tian M; Wendel AA; Belury MA
    Int J Cancer; 2010 Feb; 126(3):756-63. PubMed ID: 19634137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo.
    Titchenell PM; Chu Q; Monks BR; Birnbaum MJ
    Nat Commun; 2015 May; 6():7078. PubMed ID: 25963408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.